Patent: 6,828,121
✉ Email this page to a colleague
Summary for Patent: 6,828,121
| Title: | Bacterial host strains |
| Abstract: | An E. coli strain is described that is deficient in chromosomal degP and prc encoding protease DegP and Prc, respectively, and harbors a mutant spr gene that encodes a protein that suppresses growth phenotypes exhibited by strains harboring prc mutants. Preferably, the strain comprises nucleic acid encoding a polypeptide heterologous to the strain, so that a heterologous polypeptide can be produced therefrom. |
| Inventor(s): | Christina Yu-Ching Chen |
| Assignee: | Genentech Inc |
| Application Number: | US10/011,125 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,828,121
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | June 30, 2006 | 6,828,121 | 2021-12-07 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | August 10, 2012 | 6,828,121 | 2021-12-07 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | October 13, 2016 | 6,828,121 | 2021-12-07 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | March 20, 2018 | 6,828,121 | 2021-12-07 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,828,121
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200304101 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 0248376 | ⤷ Start Trial |
| United States of America | 2002142388 | ⤷ Start Trial |
| Russian Federation | 2287574 | ⤷ Start Trial |
| Russian Federation | 2003121232 | ⤷ Start Trial |
| Poland | 366194 | ⤷ Start Trial |
| Poland | 205897 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
